1. Home
  2. VERA vs CIM Comparison

VERA vs CIM Comparison

Compare VERA & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • CIM
  • Stock Information
  • Founded
  • VERA 2016
  • CIM 2007
  • Country
  • VERA United States
  • CIM United States
  • Employees
  • VERA N/A
  • CIM N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • CIM Real Estate Investment Trusts
  • Sector
  • VERA Health Care
  • CIM Real Estate
  • Exchange
  • VERA Nasdaq
  • CIM Nasdaq
  • Market Cap
  • VERA 1.4B
  • CIM 1.1B
  • IPO Year
  • VERA 2021
  • CIM 2007
  • Fundamental
  • Price
  • VERA $21.27
  • CIM $13.68
  • Analyst Decision
  • VERA Buy
  • CIM Buy
  • Analyst Count
  • VERA 8
  • CIM 3
  • Target Price
  • VERA $64.29
  • CIM $15.50
  • AVG Volume (30 Days)
  • VERA 1.2M
  • CIM 492.1K
  • Earning Date
  • VERA 08-05-2025
  • CIM 08-06-2025
  • Dividend Yield
  • VERA N/A
  • CIM 10.81%
  • EPS Growth
  • VERA N/A
  • CIM N/A
  • EPS
  • VERA N/A
  • CIM 1.28
  • Revenue
  • VERA N/A
  • CIM $312,281,000.00
  • Revenue This Year
  • VERA N/A
  • CIM $18.51
  • Revenue Next Year
  • VERA N/A
  • CIM $3.88
  • P/E Ratio
  • VERA N/A
  • CIM $10.66
  • Revenue Growth
  • VERA N/A
  • CIM 1.91
  • 52 Week Low
  • VERA $18.53
  • CIM $9.85
  • 52 Week High
  • VERA $51.61
  • CIM $16.89
  • Technical
  • Relative Strength Index (RSI)
  • VERA 48.60
  • CIM 48.36
  • Support Level
  • VERA $19.07
  • CIM $13.29
  • Resistance Level
  • VERA $22.74
  • CIM $13.85
  • Average True Range (ATR)
  • VERA 0.97
  • CIM 0.27
  • MACD
  • VERA 0.13
  • CIM -0.00
  • Stochastic Oscillator
  • VERA 59.99
  • CIM 60.07

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Share on Social Networks: